Literature DB >> 2509678

Toxicity of intraperitoneal doses of microcystin-LR in two strains of male mice.

R A Lovell1, D J Schaeffer, S B Hooser, W M Haschek, A M Dahlem, W W Carmichael, V R Beasley.   

Abstract

Male Balb/C and Swiss Webster (SW) mice were administered various i.p. doses of microcystin-LR (MCLR) to establish dose-response curves and to determine if a sublethal dose of MCLR would protect against an approximate LD100 min given 2 or 3 days later. Micocystin-LR has an extremely steep dose-lethal response curve in BC mice--LD50 = 32.5 micrograms (micrograms)/kg, approximate LD0 max = 25 micrograms/kg and approximate LD100 min = 40 micrograms/kg. Liver weights increased 64% (BC) and 51% (SW) and kidney weights increased 32% (BC) and 20% (SW) within 200 minutes following administration of an approximate LD100 min of MCLR in naive mice. Grossly and histologically the marked increase in liver weight appeared to be caused primarily from intrahepatic hemorrhage and death is probably a result of hemorrhagic shock. Twenty-four hours following administration of a sublethal dose of MCLR to naive BC mice, liver weights were increased significantly (8.7%), but no clinical signs or histologic lesions were observed. In SW mice, administration of a LD23 of MCLR resulted in significantly increased survivability and survival times when an approximate LD100 min of MCLR was given 3 days later. Survivors of the LD23/LD100 min regimen had 96 hour postdosing liver weights not significantly different from those of mice which died acutely after the same hepatotoxin treatments. These survivors showed weakness, recumbency, anorexia, and icterus, and had marked gross liver lesions. Histologically these lesions were undergoing rapid reparative processes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2509678

Source DB:  PubMed          Journal:  J Environ Pathol Toxicol Oncol        ISSN: 0731-8898            Impact factor:   3.567


  8 in total

1.  Hepatitis B virus x gene and cyanobacterial toxins promote aflatoxin B1-induced hepatotumorigenesis in mice.

Authors:  Min Lian; Ying Liu; Shun-Zhang Yu; Geng-Sun Qian; Shu-Guang Wan; Kenneth-R Dixon
Journal:  World J Gastroenterol       Date:  2006-05-21       Impact factor: 5.742

Review 2.  Cyanobacterial cyclopeptides as lead compounds to novel targeted cancer drugs.

Authors:  Ioannis Sainis; Demosthenes Fokas; Katerina Vareli; Andreas G Tzakos; Valentinos Kounnis; Evangelos Briasoulis
Journal:  Mar Drugs       Date:  2010-03-15       Impact factor: 5.118

Review 3.  α,β-Dehydroamino acids in naturally occurring peptides.

Authors:  Dawid Siodłak
Journal:  Amino Acids       Date:  2014-10-17       Impact factor: 3.520

4.  The Comparative Toxicity of 10 Microcystin Congeners Administered Orally to Mice: Clinical Effects and Organ Toxicity.

Authors:  Neil Chernoff; Donna Hill; Johnsie Lang; Judy Schmid; Thao Le; Amy Farthing; Hwa Huang
Journal:  Toxins (Basel)       Date:  2020-06-18       Impact factor: 4.546

5.  Dose-Response Study of Microcystin Congeners MCLA, MCLR, MCLY, MCRR, and MCYR Administered Orally to Mice.

Authors:  Neil Chernoff; Donna Hill; Johnsie Lang; Judith Schmid; Amy Farthing; Hwa Huang
Journal:  Toxins (Basel)       Date:  2021-01-24       Impact factor: 4.546

6.  Hepatotoxic seafood poisoning (HSP) due to microcystins: a threat from the ocean?

Authors:  Katerina Vareli; Walter Jaeger; Anastasia Touka; Stathis Frillingos; Evangelos Briasoulis; Ioannis Sainis
Journal:  Mar Drugs       Date:  2013-08-05       Impact factor: 5.118

7.  Repeated five-day administration of L-BMAA, microcystin-LR, or as mixture, in adult C57BL/6 mice - lack of adverse cognitive effects.

Authors:  Oddvar Myhre; Dag Marcus Eide; Synne Kleiven; Hans Christian Utkilen; Tim Hofer
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

Review 8.  Cyanobacterial Toxins of the Laurentian Great Lakes, Their Toxicological Effects, and Numerical Limits in Drinking Water.

Authors:  Todd R Miller; Lucas J Beversdorf; Chelsea A Weirich; Sarah L Bartlett
Journal:  Mar Drugs       Date:  2017-06-02       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.